Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study

Background  There is little evidence on how the occurrence of a bleed in individuals on vitamin K antagonists (VKAs) impacts the risk of subsequent bleeds, and thromboembolic and ischemic events. Such information would help to inform treatment decisions following bleeds. Objective  To estimate the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Alikhan, Raza, Lefevre, Cinira, Menown, Ian, Lister, Steven, Bird, Alex, You, Min, Evans, David, Sammon, Cormac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777986/
https://www.ncbi.nlm.nih.gov/pubmed/31592518
http://dx.doi.org/10.1055/s-0039-1698413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777986/
https://www.ncbi.nlm.nih.gov/pubmed/31592518
http://dx.doi.org/10.1055/s-0039-1698413

Ejemplares similares